The Food and Drug Administration granted accelerated approval to lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) on February 16, 2024. This approval is for adult patients with unresectable or met...
Targeted therapy for sarcoma treatment No stranger to cancer, not much information about sarcoma. In fact, sarcoma is a type of cancer that is often ignored by people. This kind of cancer appears in ...